Moreover, the key role of NLRP3and diabetes in COVID-19 infection is well discussed, and several hypoglycemic agents have been proposed as an adjunctive treatment for diabetic patients infected with COVID-19 regarding NLRP3.Although further clinical trials are needed to address this issue, it is promising to consider the current research progress. This evidence concerns the gene NLRP3 and diabetes mellitus.